A Phase I, Open Label, Randomized, Three Period, Fixed Sequence Crossover Study to Evaluate the Effect of Carbamazepine on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (200901)
Latest Information Update: 20 Nov 2023
At a glance
- Drugs Dolutegravir (Primary) ; Carbamazepine
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors ViiV Healthcare
- 22 Feb 2016 Results published in the European Journal of Clinical Pharmacology
- 23 Jan 2014 According to ClinicalTrials.gov record study status changed to completed.
- 30 Oct 2013 New trial record